Understanding how certain proteins affect liver and gastrointestinal cancers
Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers
This study is looking at how certain proteins in the liver interact with each other and how this might affect the development of liver cancer in people with a liver condition called NASH, with the hope of finding new ways to treat or prevent cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Feinstein Institute for Medical Research NIH-funded |
| Lab location | 1 site (Manhasset, United States) |
| Project ID | NIH-11067815 on NIH RePORTER |
What this research studies
This research investigates the interactions between proteins involved in the TGF-beta signaling pathway and epigenetic regulators in the context of liver and gastrointestinal cancers. It focuses on how these interactions may influence the progression of liver diseases, particularly in patients with non-alcoholic steatohepatitis (NASH) who develop hepatocellular cancer (HCC). By studying specific proteins like SIRT6 and β2-spectrin, the research aims to uncover mechanisms that could lead to new therapeutic strategies. Patients may benefit from insights that could improve treatment options or prevention strategies for liver cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with non-alcoholic steatohepatitis (NASH) or those at risk of developing hepatocellular cancer (HCC).
Not a fit: Patients with cancers unrelated to liver or gastrointestinal systems may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments or preventive measures for patients at risk of liver and gastrointestinal cancers.
How similar studies have performed: Other research has shown promising results in understanding the role of TGF-beta signaling in cancer, indicating that this approach has potential for success.
Where this research is happening
Manhasset, United States
- Feinstein Institute for Medical Research — Manhasset, United States (Active)
Researchers
- Principal investigator: Mishra, Lopa — Feinstein Institute for Medical Research
- Study coordinator: Mishra, Lopa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.